US
CA
NZ
UK
AU
IND
Last update at 2025-06-11T13:30:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Asahi Kasei Microdevices Launches New Series of Power Management ICs for Energy Harvesting
Tue 06 May 25, 12:30 PMAsahi Kasei Bioprocess America Wins Best Technologies Innovation Award at INTERPHEX 2025
Mon 28 Apr 25, 12:30 PMKen Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector
Thu 24 Apr 25, 12:53 PMAsahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward
Tue 08 Apr 25, 12:30 PMBionova Opens Fremont Process Development and Pilot Plant
Tue 04 Mar 25, 01:30 PM| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | -61906.00000M | 215121.00M | 150906.00M | 155934.00M | 210397.00M |
| Minority interest | -1942.00000M | -1954.00000M | 27058.00M | 24145.00M | 21225.00M |
| Net income | -91312.00000M | 161880.00M | 79768.00M | 103931.00M | 147512.00M |
| Selling general administrative | - | - | - | - | 416036.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 773776.00M | 769768.00M | 680709.00M | 675040.00M | 688548.00M |
| Reconciled depreciation | 176651.00M | 148129.00M | 133272.00M | 118304.00M | 104046.00M |
| Ebit | 127443.00M | 215695.00M | 178627.00M | 188023.00M | 224347.00M |
| Ebitda | 304094.00M | 363824.00M | 311899.00M | 306327.00M | 328393.00M |
| Depreciation and amortization | 176651.00M | 148129.00M | 133272.00M | 118304.00M | 104046.00M |
| Non operating income net other | - | - | - | - | 0.00000M |
| Operating income | 128352.00M | 202647.00M | 171808.00M | 177264.00M | 209587.00M |
| Other operating expenses | 2598133.00M | 2258671.00M | 1934243.00M | 1974382.00M | 1960815.00M |
| Interest expense | 5907.00M | 3643.00M | 3209.00M | 4016.00M | 4371.00M |
| Tax provision | 27464.00M | 51287.00M | 68808.00M | 50206.00M | 60582.00M |
| Interest income | 3896.00M | 1364.00M | 1895.00M | 2769.00M | 3094.00M |
| Net interest income | -2011.00000M | -2279.00000M | -1314.00000M | -1247.00000M | -1277.00000M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.00000M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | 27464.00M | 51287.00M | 68808.00M | 50206.00M | 60582.00M |
| Total revenue | 2726485.00M | 2461317.00M | 2106051.00M | 2151646.00M | 2170403.00M |
| Total operating expenses | 645424.00M | 567122.00M | 508901.00M | 497776.00M | 478960.00M |
| Cost of revenue | 1952709.00M | 1691549.00M | 1425342.00M | 1476606.00M | 1481855.00M |
| Total other income expense net | -190258.00000M | 12474.00M | -20902.00000M | -21330.00000M | 810.00M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | -89370.00000M | 163834.00M | 82098.00M | 105727.00M | 149816.00M |
| Net income applicable to common shares | - | 161880.00M | 79768.00M | 103931.00M | 147512.00M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 3454526.00M | 3349075.00M | 2918941.00M | 2797975.00M | 2575203.00M |
| Intangible assets | 368695.00M | 405508.00M | 342453.00M | 215947.00M | 210080.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 151769.00M | 114724.00M | 94906.00M | 90634.00M | 79438.00M |
| Total liab | 1758517.00M | 1630259.00M | 1424407.00M | 1414514.00M | 1172493.00M |
| Total stockholder equity | 1660922.00M | 1687411.00M | 1467476.00M | 1359316.00M | 1381485.00M |
| Deferred long term liab | - | - | - | - | 0.00000M |
| Other current liab | 364805.00M | 391043.00M | 331625.00M | 295647.00M | 306681.00M |
| Common stock | 103389.00M | 103389.00M | 103389.00M | 103389.00M | 103389.00M |
| Capital stock | 103389.00M | 103389.00M | 103389.00M | 103389.00M | 103389.00M |
| Retained earnings | 1142325.00M | 1282325.00M | 1158792.00M | 1125738.00M | 1077586.00M |
| Other liab | - | 283910.00M | 286919.00M | 303607.00M | 260509.00M |
| Good will | 368089.00M | 431335.00M | 351921.00M | 469535.00M | 319898.00M |
| Other assets | - | 1.00M | 1.00M | 1.00M | 1.00M |
| Cash | 251181.00M | 244641.00M | 221779.00M | 207957.00M | 193893.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 912163.00M | 923850.00M | 703163.00M | 842531.00M | 681853.00M |
| Current deferred revenue | 254120.00M | 280264.00M | 243093.00M | 223787.00M | 224805.00M |
| Net debt | 723567.00M | 532574.00M | 441997.00M | 500398.00M | 230981.00M |
| Short term debt | 366798.00M | 354715.00M | 229451.00M | 415677.00M | 194743.00M |
| Short long term debt | 360032.00M | 352491.00M | 228571.00M | 414671.00M | 194579.00M |
| Short long term debt total | 974748.00M | 777215.00M | 663776.00M | 708355.00M | 424874.00M |
| Other stockholder equity | 415208.00M | 301697.00M | 205295.00M | 130189.00M | 200510.00M |
| Property plant equipment | - | 805215.00M | 717262.00M | 653685.00M | 621366.00M |
| Total current assets | 1488195.00M | 1334209.00M | 1136776.00M | 1107430.00M | 1051393.00M |
| Long term investments | - | - | - | - | 324964.00M |
| Net tangible assets | - | 850567.00M | 773101.00M | 644070.00M | 851507.00M |
| Short term investments | - | - | - | - | 0.00000M |
| Net receivables | 442692.00M | 434595.00M | 338640.00M | 330999.00M | 350716.00M |
| Long term debt | 579424.00M | 413785.00M | 430404.00M | 289172.00M | 229878.00M |
| Inventory | 642553.00M | 540249.00M | 481451.00M | 477840.00M | 427346.00M |
| Accounts payable | 180560.00M | 178092.00M | 142087.00M | 131207.00M | 180429.00M |
| Total permanent equity | - | - | - | - | 0.00000M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 0.00000M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | 0.00000M |
| Accumulated other comprehensive income | - | - | - | - | 0.00000M |
| Additional paid in capital | - | - | - | - | 0.00000M |
| Common stock total equity | - | - | - | - | 0.00000M |
| Preferred stock total equity | - | - | - | - | 0.00000M |
| Retained earnings total equity | - | - | - | - | 0.00000M |
| Treasury stock | - | - | - | - | 0.00000M |
| Accumulated amortization | - | - | - | - | 0.00000M |
| Non currrent assets other | 311930.00M | 318531.00M | 349412.00M | 301447.00M | 344957.00M |
| Deferred long term asset charges | - | - | - | - | 0.00000M |
| Non current assets total | 1966331.00M | 2014865.00M | 1782164.00M | 1690544.00M | 1523809.00M |
| Capital lease obligations | 35292.00M | 10939.00M | 4801.00M | 4512.00M | 417.00M |
| Long term debt total | - | - | - | - | 0.00000M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -213584.00000M | 31589.00M | 10274.00M | 21871.00M | 8474.00M |
| Change to liabilities | - | 31576.00M | 1706.00M | -45562.00000M | 5083.00M |
| Total cashflows from investing activities | - | -221019.00000M | -157751.00000M | -318156.00000M | -198917.00000M |
| Net borrowings | - | 94434.00M | -48336.00000M | 280976.00M | 71819.00M |
| Total cash from financing activities | 111780.00M | 42321.00M | -95869.00000M | 221923.00M | 17388.00M |
| Change to operating activities | - | -13276.00000M | 33005.00M | -19826.00000M | 18809.00M |
| Net income | -61906.00000M | 215121.00M | 150906.00M | 155934.00M | 210397.00M |
| Change in cash | 4955.00M | 26713.00M | 11464.00M | 24251.00M | 31924.00M |
| Begin period cash flow | 242948.00M | 216235.00M | 204771.00M | 180520.00M | 148596.00M |
| End period cash flow | 247903.00M | 242948.00M | 216235.00M | 204771.00M | 180520.00M |
| Total cash from operating activities | 90804.00M | 183271.00M | 253676.00M | 124460.00M | 212062.00M |
| Issuance of capital stock | 208.00M | 125.00M | 69.00M | 84.00M | 40.00M |
| Depreciation | 176651.00M | 148129.00M | 133272.00M | 118304.00M | 104046.00M |
| Other cashflows from investing activities | - | 52.00M | -296.00000M | 370.00M | -3423.00000M |
| Dividends paid | -48575.00000M | -47187.00000M | -45800.00000M | -48723.00000M | -51674.00000M |
| Change to inventory | -84053.00000M | -73257.00000M | 6110.00M | -51950.00000M | -57968.00000M |
| Change to account receivables | - | -45911.00000M | 5214.00M | 16919.00M | 3942.00M |
| Sale purchase of stock | -1415.00000M | -412.00000M | -10.00000M | -10016.00000M | -40.00000M |
| Other cashflows from financing activities | 237023.00M | 140889.00M | -33192.00000M | 318164.00M | 159735.00M |
| Change to netincome | - | -79111.00000M | -5399.00000M | 2644.00M | -72088.00000M |
| Capital expenditures | 172158.00M | 169708.00M | 150292.00M | 154450.00M | 124854.00M |
| Change receivables | - | - | - | - | 0.00000M |
| Cash flows other operating | - | - | - | - | 0.00000M |
| Exchange rate changes | - | - | - | - | 0.00000M |
| Cash and cash equivalents changes | - | - | - | - | 0.00000M |
| Change in working capital | -81107.00000M | -81756.00000M | 30139.00M | -79731.00000M | -45462.00000M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | 57166.00M | -98223.00000M | -60641.00000M | -70047.00000M | -56919.00000M |
| Free cash flow | -81354.00000M | 13563.00M | 103384.00M | -29990.00000M | 87208.00M |
Sector: Basic Materials Industry: Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHKSF Asahi Kasei Corporation |
- -% | 6.55 | - | - | 0.0036 | 0.75 | 0.0054 | 0.15 |
| SHECY Shin-Etsu Chemical Co Ltd ADR |
-0.29 1.80% | 15.82 | 18.83 | 12.18 | 0.03 | 2.62 | 0.03 | 0.06 |
| SHECF Shin-Etsu Chemical Co. Ltd |
0.98 3.21% | 31.50 | 18.24 | 12.11 | 0.03 | 2.68 | 0.03 | 0.06 |
| BASFY BASF SE ADR |
0.08 0.65% | 12.35 | - | 11.93 | 0.66 | 1.10 | 0.94 | 21.29 |
| BFFAF BASF SE NA O.N. |
1.64 3.39% | 50.00 | 83.72 | 12.15 | 0.66 | 1.14 | 0.92 | 7.92 |
Asahi Kasei Corporation manufactures and sells chemicals. It offers caustic soda, chemical fertilizers, nitric acid, ammonia, acrylonitrile, methyl methacrylate, styrene, adipic acid, hexamethylene diamine, AH salt, propionitrile, sodium cyanide, acetonitrile, methacrylonitrile, cyclohexyl methacrylate, polyethylenes, polyethylenes powder, PMMA resin, polystyrene, polybutadiene rubbers, styrene/butadiene rubbers, clear styrenic copolymer, styrenic thermoplastic elastomer, hydrogenated styrenic elastomers, membranes and systems, functional materials, foams, purging compound, polyisocyanates, polycarbonatediol, aluminum paste, latex, photopolymers and platemaking systems, films, cyclohexanol, cyclohexane, and cyclohexene. The company also offers lithium-ion battery and lead-acid battery separators, plastic optical fibers, artificial suede, nylon 66 filament, polyamide 66, polyacetal, polyphenyene ether, polypropylene compounds, 3D cubic knitted fabric, noise suppression sheets, audio devices, photosensitive polyimide/PBO precursor, latent hardeners, glass fabrics, specialty products, explosion-bonded metal clads, lining fabrics, cupro and stretch fibers, oil-water separators, cellulose nanobeads, and flame-resistant and synthetic fiber; magnetic, current, and gas sensors; deodorizing, spunbond, cupro, multifunctional, and heat-press formable thermoplastic nonwoven; and ecorise, biocradle, and bemliese products. It provides bags and containers; cooking products; cleaners; plastic packet cutting products; cyclohexyl methacrylate, bonded anchors, and microcrystalline cellulose; pharmaceuticals and diagnostic reagents, dialyzers, therapeutic apheresis, virus removal filters, defibrillators, AEDs, automated CPRs, fluid resuscitation pumps, wearable defibrillators, temperature management systems, and data solutions; construction materials; and remodeling services, as well as develops homes and apartments. The company was founded in 1922 and is headquartered in Tokyo, Japan.
Hibiya Mitsui Tower, Tokyo, Japan, 100-0006
| Name | Title | Year Born |
|---|---|---|
| Mr. Koshiro Kudo | CFO, Presial Exec. Officer, Pres & Representative Director | 1959 |
| Mr. Toshiyasu Horie | Sr. Exec. Officer, Exec. Officer for Strategy, Accounting & Fin., IR and Director | 1962 |
| Futoshi Hamamoto | Gen. Mang. of Investor Relations | NA |
| Hiroki Ideguchi | Sr. Exec. Officer and Exec. Officer for Genl Affairs, Legal, Comm. Risk Mgmt. & Compliance, HR | NA |
| Mr. Shuichi Sakamoto | Primary Exec. Officer for Health Care Bus. Sector (joint) & Director | 1957 |
| Dr. Ichiro Oyama M.D. | Chief Industrial Physician | NA |
| Mr. Richard A. Packer | Primary Exec. Officer & Exec. Officer for Health Care Bus. Sector (Joint) | 1958 |
| Mr. Kenji Hamai | Primary Exec. Officer | NA |
| Hideyuki Yamagishi | Primary Exec. Officer | NA |
| Mr. John W. Moyer | Sr. Exec. Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...